Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2020-11-03 07:59:29]
5 Years H
13
Impact Factor
0.12
5 Years IF
0.15
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.11 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.12 0 0 0 0 0 0 0 0 0 0 0.06
1995 0 0.2 0 0 0 0 0 0 0 0 0 0 0.09
1996 0 0.23 0 0 0 0 0 0 0 0 0 0 0.11
1997 0 0.23 0 0 10 10 6 0 0 0 0 0 0.1
1998 0 0.27 0 0 12 22 3 0 10 10 0 0 0.13
1999 0 0.29 0.18 0 0 22 0 4 22 22 0 0 0.14
2000 0 0.34 0.03 0.05 9 31 0 1 5 12 22 1 0 0 0.15
2001 0 0.36 0 0 3 34 0 5 9 31 0 0 0.16
2002 0 0.4 0.03 0.03 0 34 0 1 6 12 34 1 0 0 0.21
2003 0 0.41 0.03 0 5 39 3 1 7 3 24 0 0 0.2
2004 0 0.46 0.03 0 1 40 1 1 8 5 17 0 0 0.2
2005 0 0.47 0.02 0 7 47 4 1 9 6 18 0 0 0.22
2006 0 0.47 0.03 0.13 62 109 57 3 12 8 16 2 1 33.3 0 0.21
2007 0.03 0.43 0.02 0.03 38 147 26 3 15 69 2 75 2 0 0 0.19
2008 0.01 0.45 0.01 0.01 22 169 113 1 16 100 1 113 1 1 100 0 0.21
2009 0 0.44 0.02 0.01 28 197 23 3 19 60 130 1 0 0 0.21
2010 0.12 0.44 0.05 0.06 33 230 35 11 30 50 6 157 10 0 0 0.18
2011 0.05 0.47 0.05 0.04 32 262 72 12 42 61 3 183 8 3 25 2 0.06 0.21
2012 0.15 0.47 0.11 0.14 87 349 105 38 80 65 10 153 22 4 10.5 6 0.07 0.19
2013 0.26 0.53 0.18 0.22 96 445 243 78 158 119 31 202 45 21 26.9 13 0.14 0.22
2014 0.21 0.54 0.19 0.17 123 568 241 110 268 183 38 276 47 30 27.3 34 0.28 0.21
2015 0.3 0.54 0.24 0.25 105 673 155 159 427 219 66 371 94 28 17.6 14 0.13 0.21
2016 0.27 0.54 0.23 0.27 145 818 127 186 613 228 62 443 120 34 18.3 10 0.07 0.19
2017 0.2 0.55 0.21 0.21 116 934 104 196 809 250 49 556 116 49 25 23 0.2 0.2
2018 0.21 0.64 0.21 0.23 128 1062 49 223 1032 261 54 585 135 34 15.2 7 0.05 0.25
2019 0.23 0.74 0.23 0.22 132 1194 29 273 1305 244 56 617 133 45 16.5 26 0.2 0.27
2020 0.12 0.84 0.16 0.15 107 1301 7 202 1507 260 32 626 91 24 11.9 6 0.06 0.28
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

141
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

90
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

31
4Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

27
52014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

25
62012Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

23
72017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

21
82015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

19
92014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

18
102014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

15
112016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

14
122015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

14
132014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

13
142014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

13
152019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

13
162014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

13
172014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

12
182014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

12
19Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

12
202013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

11
212015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

11
222014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
232016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

10
242012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

9
252014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

9
262011Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Galarraga, Omar ; Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599.

Full description at Econpapers || Download paper

9
272006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

9
282015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

9
292016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

9
302018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

8
312014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

8
322015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

8
332012Erratum to Systematic Reviewof the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis. (2012). Fitzpatrick, C. ; Floyd, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:81-81.

Full description at Econpapers || Download paper

8
342013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

8
352017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

8
36The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

8
372012A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis. (2012). Fitzpatrick, Christopher ; Floyd, Katherine . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:63-80.

Full description at Econpapers || Download paper

8
382014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

8
392015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

8
402015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

7
412008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

7
422011Calibrating Models in Economic Evaluation. (2011). Karnon, Jonathan ; Vanni, Tazio . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:51-62.

Full description at Econpapers || Download paper

7
432006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

7
442011Calibrating Models in Economic Evaluation. (2011). Foss, Anna ; Edmunds, W. ; Vanni, Tazio ; Legood, Rosa ; White, Richard ; Karnon, Jonathan ; Madan, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:35-49.

Full description at Econpapers || Download paper

7
452015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

7
462013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

7
472016Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x.

Full description at Econpapers || Download paper

6
482011Does the Market Share of Generic Medicines Influence the Price Level?. (2011). Dylst, Pieter ; Simoens, Steven. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:10:p:875-882.

Full description at Econpapers || Download paper

6
492017Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM). (2017). Johansen, Pierre ; Willis, Michael ; Asseburg, Christian ; Nilsson, Andreas. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0471-3.

Full description at Econpapers || Download paper

6
502014Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375.

Full description at Econpapers || Download paper

6
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

26
22013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

22
32017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

16
42019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

11
52014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

11
62016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

8
72015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

7
82014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

7
92018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

6
102011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

6
112014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

5
122015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

5
132014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

5
142016From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y.

Full description at Econpapers || Download paper

4
152018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

4
162017Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US. (2017). van Exel, Job ; Hoefman, Renske J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:4:d:10.1007_s40273-016-0477-x.

Full description at Econpapers || Download paper

4
172017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

4
182018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

4
192016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

4
202013Reference Pricing and Price Negotiations for Innovative New Drugs. (2013). Gandjour, Afschin. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:11-14.

Full description at Econpapers || Download paper

4
212016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

4
222015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

4
232018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4.

Full description at Econpapers || Download paper

4
242014Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375.

Full description at Econpapers || Download paper

4
252015Economic Evaluations with Agent-Based Modelling: An Introduction. (2015). He, Tianhua ; Chhatwal, Jagpreet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:423-433.

Full description at Econpapers || Download paper

4
262017The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

4
272015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

4
282014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

4
292017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atValidation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM). (2017). Johansen, Pierre ; Willis, Michael ; Asseburg, Christian ; Nilsson, Andreas. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0471-3.

Full description at Econpapers || Download paper

3
312013Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

3
322017Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7.

Full description at Econpapers || Download paper

3
332017The Indonesian EQ-5D-5L Value Set. (2017). Purba, Fredrick Dermawan ; An, J ; Passchier, Jan ; Ramos-Goi, Juan Manuel ; Sadarjoen, Sawitri Supardi ; Fitriana, Titi Sahidah ; Iskandarsyah, Aulia. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0538-9.

Full description at Econpapers || Download paper

3
342018Discounting in Economic Evaluations. (2018). Claxton, Karl ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z.

Full description at Econpapers || Download paper

3
352015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

3
362015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

3
372018Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. (2018). Zhou, MO ; John , ; Thayer, Winter Maxwell. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0575-4.

Full description at Econpapers || Download paper

3
382015Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. (2015). Laurence, Yoko ; Vassall, Anna ; Griffiths, Ulla . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:939-955.

Full description at Econpapers || Download paper

3
392018Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?. (2018). Mattingly, Joseph T ; Perfetto, Eleanor M ; Onwudiwe, Nneka C ; Slejko, Julia F ; Levy, Joseph F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0667-9.

Full description at Econpapers || Download paper

3
402014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

3
412014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

3
422011Calibrating Models in Economic Evaluation. (2011). Karnon, Jonathan ; Vanni, Tazio . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:51-62.

Full description at Econpapers || Download paper

3
432015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

3
442011Calibrating Models in Economic Evaluation. (2011). Foss, Anna ; Edmunds, W. ; Vanni, Tazio ; Legood, Rosa ; White, Richard ; Karnon, Jonathan ; Madan, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:35-49.

Full description at Econpapers || Download paper

3
452016The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. (2016). Viney, Rosalie ; Mulhern, Brendan ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:8:d:10.1007_s40273-016-0399-7.

Full description at Econpapers || Download paper

3
462016Economic Evaluations of Opioid Use Disorder Interventions. (2016). Murphy, Sean M ; Polsky, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0400-5.

Full description at Econpapers || Download paper

3
472014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

3
482016Using Best–Worst Scaling to Investigate Preferences in Health Care. (2016). Hollin, Ilene L ; Cheung, Kei Long ; Hiligsmann, Mickael ; Silvia, ; Bridges, John F ; Janssen, Ellen M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:12:d:10.1007_s40273-016-0429-5.

Full description at Econpapers || Download paper

3
492018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. (2018). Hobbins, Anna ; Oneill, Ciaran ; Ramos, Juan Manuel ; Devlin, Nancy ; Shah, Koonal ; Kelleher, Dan ; Barry, Luke . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0690-x.

Full description at Econpapers || Download paper

3
502014Solo self-employed versus employer entrepreneurs: determinants and macro-economic effects in OECD countries. (2014). Stel, Andre ; Wennekers, Sander ; Scholman, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:107-136.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 32
YearTitle
2020Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program. (2020). Leopold, Christine ; Wagner, Anita K ; Gilkey, Melissa ; Rosenberg, Carol ; Araujo-Lane, Carina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0170-z.

Full description at Econpapers || Download paper

2020A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852.

Full description at Econpapers || Download paper

2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’. (2020). Devlin, Nancy ; Ombler, Franz ; Hansen, Paul ; Sullivan, Trudy ; Derrett, Sarah. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307026.

Full description at Econpapers || Download paper

2020Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

Full description at Econpapers || Download paper

2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values. (2020). Devlin, Nancy ; Kreimeier, Simone ; Ramos-Goi, Juan Manuel ; Shah, Koonal K. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01205-9.

Full description at Econpapers || Download paper

2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland. (2020). Shah, Koonal ; Devlin, Nancy ; Oneill, Ciaran ; Ramos, Juan Manuel ; Kelleher, Dan ; Barry, Luke ; Hobbins, Anna P. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:6:p:639-646.

Full description at Econpapers || Download paper

2020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Gerdtham, Ulf-G. ; Leidl, Reiner ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7.

Full description at Econpapers || Download paper

2020Does the EVA valuation model explain the market value of equity better under changing required return than constant required return?. (2020). Behera, Sujata. In: Financial Innovation. RePEc:spr:fininn:v:6:y:2020:i:1:d:10.1186_s40854-019-0167-8.

Full description at Econpapers || Download paper

2020Implications of Low Carbon City Sustainability Strategies for 2050. (2020). Levin, Gregor ; Weinzettel, Jan ; Harris, Steve. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:13:p:5417-:d:380420.

Full description at Econpapers || Download paper

2020Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. (2020). Gibbs, Peter ; Koopman, Miriam ; Wong, Hui-Li ; Koffijberg, Hendrik ; Vu, Martin ; Degeling, Koen ; Ijzerman, Maarten . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00908-4.

Full description at Econpapers || Download paper

2020A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations. (2020). Daniels, Michael J ; Gabrio, Andrea ; Baio, Gianluca. In: Journal of the Royal Statistical Society Series A. RePEc:bla:jorssa:v:183:y:2020:i:2:p:607-629.

Full description at Econpapers || Download paper

2020Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US. (2020). Mossialos, Elias ; Shearer, Emily ; Salas-Vega, Sebastian . In: Social Science & Medicine. RePEc:eee:socmed:v:258:y:2020:i:c:s0277953620302616.

Full description at Econpapers || Download paper

2020Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. (2020). Mattingly, Joseph T ; Khokhar, Bilal ; Love, Bryan L. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00933-3.

Full description at Econpapers || Download paper

2020A Dirichlet process mixture model of discrete choice: Comparisons and a case study on preferences for shared automated vehicles. (2020). Vij, Akshay ; Rashidi, Taha H ; Krueger, Rico. In: Journal of choice modelling. RePEc:eee:eejocm:v:36:y:2020:i:c:s1755534520300282.

Full description at Econpapers || Download paper

2020Precision Medicine: Implications for value chains and business models in life sciences. (2020). Denicolai, Stefano ; Previtali, Pietro. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:151:y:2020:i:c:s0040162519311023.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Michaud, Pierre-Carl ; Langot, Francois ; Fonseca, Raquel. In: NBER Working Papers. RePEc:nbr:nberwo:26876.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl. In: Cahiers de recherche / Working Papers. RePEc:rsi:creeic:2004.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl ; Benito, Raquel Fonseca. In: CIRANO Working Papers. RePEc:cir:cirwor:2020s-16.

Full description at Econpapers || Download paper

2020Can healthcare choice be predicted using stated preference data?. (2020). Swait, Joffre ; Donkers, Bas ; Bliemer, Michiel ; de Bekker-Grob, E W ; Veldwijk, J ; Bliemer, M. C. J., . In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307312.

Full description at Econpapers || Download paper

2020Non-monetary numeraires: Varying the payment vehicle in a choice experiment for health interventions in Uganda. (2020). , Poppy ; Mujumbusi, Lazaaro ; Hanley, Nick ; Meginnis, Keila . In: Ecological Economics. RePEc:eee:ecolec:v:170:y:2020:i:c:s0921800919314120.

Full description at Econpapers || Download paper

2020Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0.

Full description at Econpapers || Download paper

2020Incorporating discrete choice experiments into policy decisions: Case of designing public long-term care insurance. (2020). Wasi, Nada ; Chandoevwit, Worawan. In: Social Science & Medicine. RePEc:eee:socmed:v:258:y:2020:i:c:s027795362030263x.

Full description at Econpapers || Download paper

2020Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. (2020). Peay, Holly ; DiSantostefano, Rachael ; Vass, Caroline ; Beusterien, Kathleen ; Coast, Joanna ; Craig, Benjamin M ; Hollin, Ilene L. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:1:d:10.1007_s40271-019-00401-x.

Full description at Econpapers || Download Empirical Investigation of Ranking vs Best–Worst Scaling Generated Preferences for Attributes of Quality of Life: One and the Same or Differentiable?. (2020). Ratcliffe, Julie ; Lancsar, Emily ; Hutchinson, Claire ; Kaambwa, Billingsley. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:3:d:10.1007_s40271-019-00406-6.

Full description at Econpapers || Download paper

2020Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample. (2020). Baji, Petra ; Gulacsi, Laszlo ; Klazinga, Niek ; Kringos, Dionne ; Pentek, Marta ; Fernandes, Oscar Brito. In: PLOS ONE. RePEc:plo:pone00:0235165.

Full description at Econpapers || Download paper

2020Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods. (2020). Bahrampour, Mina ; Downes, Martin ; Scuffham, Paul A ; Norman, Richard ; Byrnes, Joshua. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01189-6.

Full description at Econpapers || Download paper

2020Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements. (2020). Johansen, Pierre ; Buchholtz, Kristine ; Moreno, Soren Ilsoe ; Bishop, Ryan ; Howard, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-019-00881-7.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations. (2020). Richardson, Gerry ; Lomas, James ; Franklin, Matthew. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00907-5.

Full description at Econpapers || Download paper

2020Prediction of Claims in Export Credit Finance: A Comparison of Four Machine Learning Techniques. (2020). Krummaker, Simone ; Bartl, Mathias. In: Risks. RePEc:gam:jrisks:v:8:y:2020:i:1:p:22-:d:326934.

Full description at Econpapers || Download paper

2020Social, ethical, and other value judgments in health economics modelling. (2020). Silva, Diego S ; Werker, Gregory R ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:253:y:2020:i:c:s0277953620301945.

Full description at Econpapers || Download paper

2020Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations. (2020). Roijen, Leona Hakkaart-Van ; Brouwer, Werner ; van Domburgh, Lieke ; Kaminer, Yifrah ; Goorden, Maartje ; Reckers-Droog, Vivian. In: PLOS ONE. RePEc:plo:pone00:0238858.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2020

YearCiting document
2020Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1.

Full description at Econpapers || Download paper

2020External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Foos, Volker ; Olivieri, Anamaria-Vera ; McEwan, Phil ; Lamotte, Mark ; Lopes, Sandra. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3.

Full description at Econpapers || Download paper

2020Reflections on NICE’s Uptake of New Methods: Past, Present, and the 2020 Review. (2020). Watson, Ian ; Boysen, Meindert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-020-00888-5.

Full description at Econpapers || Download paper

2020Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard ; Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9.

Full description at Econpapers || Download paper

2020Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?. (2020). Prasad, Vinay ; Tran, Audrey A. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00920-8.

Full description at Econpapers || Download paper

2020Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?. (2020). Omahony, James F. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00931-5.

Full description at Econpapers || Download paper

Recent citations received in 2019

YearCiting document
2019Insight of Artificial Intelligence Application in Healthcare. (2019). Kuang, Cedric. In: International Journal of Sciences. RePEc:adm:journl:v:8:y:2019:i:8:p:50-55.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:halshs-02136103.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Shogren, Jason ; Jacquemet, Nicolas ; Watson, Verity ; Luchini, Stephane. In: Post-Print. RePEc:hal:journl:halshs-02136103.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Documents de travail du Centre d'Economie de la Sorbonne. RePEc:mse:cesdoc:19007.

Full description at Econpapers || Download paper

2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108.

Full description at Econpapers || Download paper

2019The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. (2019). Brouwer, Werner ; Baji, Petra ; Pentek, Marta ; Gulacsi, Laszlo ; Zrubka, Zsombor ; Prevolnik-Rupel, Valentina ; Golicki, Dominik. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01058-x.

Full description at Econpapers || Download paper

2019Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. (2019). Basu, Anirban ; Walton, Surrey M ; Carlson, Josh J ; Ollendorf, Daniel A ; Whittington, Melanie D ; Veenstra, David ; Touchette, Daniel R ; Pearson, Steven D ; McQueen, Brett R ; Campbell, Jonathan D ; Chapman, Richard H. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00832-2.

Full description at Econpapers || Download Improving Transparency in Decision Models: Current Issues and Potential Solutions. (2019). Caro, Jaime J ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00850-0.

Full description at Econpapers || Download paper

2019Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature. (2019). Wittenberg, Eve ; Prosser, Lisa A ; James, Lyndon P. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7.

Full description at Econpapers || Download paper

2019Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness. (2019). Prosser, Lisa A ; Wittenberg, Eve . In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00794-5.

Full description at Econpapers || Download paper

2019Response to ‘Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”â€. (2019). Guy, Holly ; Fisher, Mark ; Walder, Lydia. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:7:d:10.1007_s40273-019-00803-7.

Full description at Econpapers || Download paper

2019U.K. utility weights for the EORTC QLU‐C10D. (2019). Viney, Rosalie ; Street, Deborah J ; Pickard, Simon A ; Cella, David ; Brazier, John E ; Rowen, Donna ; Consortium, The Mauca ; Merciecabebber, Rebecca ; Of, Treatment ; Norman, Richard ; King, Madeleine T ; Revicki, Dennis. In: Health Economics. RePEc:wly:hlthec:v:28:y:2019:i:12:p:1385-1401.

Full description at Econpapers || Download paper

Recent citations received in 2018

YearCiting document
2018Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13. (2018). Claxton, Karl ; Martin, Stephen ; Lomas, James. In: Working Papers. RePEc:chy:respap:158cherp.

Full description at Econpapers || Download paper

2018Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. (2018). Fu, Hongqiao ; Yip, Winnie ; Li, Ling. In: Social Science & Medicine. RePEc:eee:socmed:v:211:y:2018:i:c:p:114-122.

Full description at Econpapers || Download paper

2018Model Structuring for Economic Evaluations of New Health Technologies. (2018). Ali, Hossein Haji ; Karnon, Jonathan ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0693-7.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

20183L, 5L, What the L? A NICE Conundrum. (2018). Devlin, Nancy ; Stolk, Elly ; Pickard, Simon A ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0622-9.

Full description at Econpapers || Download paper

2018A Bayesian framework for health economic evaluation in studies with missing data. (2018). Gomes, Manuel ; Carpenter, James R ; Grieve, Richard ; Mason, Alexina J. In: Health Economics. RePEc:wly:hlthec:v:27:y:2018:i:11:p:1670-1683.

Full description at Econpapers || Download paper

2018Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey. (2018). Gomes, Manuel ; Carpenter, James R ; Leurent, Baptiste. In: Health Economics. RePEc:wly:hlthec:v:27:y:2018:i:6:p:1024-1040.

Full description at Econpapers || Download paper

Recent citations received in 2017

YearCiting document
2017Valuing Informal Care in Ireland: Beyond the Traditional Production Boundary. (2017). Hanly, Paul ; Sheerin, Corina. In: The Economic and Social Review. RePEc:eso:journl:v:48:y:2017:i:3:p:337-364.

Full description at Econpapers || Download paper

2017Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9.

Full description at Econpapers || Download paper

2017The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States. (2017). Levitan, Bennett ; Christopher, Stephanie ; Jaffe, Ross ; Damiano, Marina G ; Hauber, Brett A. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:10:y:2017:i:5:d:10.1007_s40271-017-0272-6.

Full description at Econpapers || Download paper

2017Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. (2017). Salleh, Syed ; Dixon, Simon ; Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0533-1.

Full description at Econpapers || Download paper

2017Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5.

Full description at Econpapers || Download paper

2017Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3.

Full description at Econpapers || Download paper

2017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atHeath State Utility Values for Cost-Effectiveness Models. (2017). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0537-x.

Full description at Econpapers || Download paper

2017The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment. (2017). Rowen, Donna ; Zouraq, Ismail Azzabi ; Ara, Roberta ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0546-9.

Full description at Econpapers || Download paper

2017The Identification, Review and Synthesis of Health State Utility Values from the Literature. (2017). Ara, Roberta ; Paisley, Suzy ; Peasgood, Tessa ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0547-8.

Full description at Econpapers || Download paper

2017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

2017Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. (2017). Ara, Roberta ; Young, Tracey ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0549-6.

Full description at Econpapers || Download paper

2017The Use of Health State Utility Values in Decision Models. (2017). Ara, Roberta ; Zouraq, Ismail Azzabi ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0550-0.

Full description at Econpapers || Download paper

2017Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NI. (2017). , Bram ; Joore, Manuela A ; Kleijnen, Jos ; Severens, Johan L ; Armstrong, Nigel ; Duffy, Steven ; Deshpande, Sohan ; Asselt, Thea ; Tomini, Florian ; Riemsma, Rob. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0507-3.

Full description at Econpapers || Download An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments. (2017). Engel, Lidia ; David, ; Lear, Scott A ; Bryan, Stirling ; Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0491-7.

Full description at Econpapers || Download paper

2017Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2.

Full description at Econpapers || Download paper